| Literature DB >> 21666793 |
Johnathan J Dalzell1, Paul McVeigh, Neil D Warnock, Makedonka Mitreva, David McK Bird, Pierre Abad, Colin C Fleming, Tim A Day, Angela Mousley, Nikki J Marks, Aaron G Maule.
Abstract
While RNA interference (RNAi) has been deployed to facilitate gene function studies in diverse helminths, parasitic nematodes appear variably susceptible. To test if this is due to inter-species differences in RNAi effector complements, we performed a primary sequence similarity survey for orthologs of 77 Caenorhabditis elegans RNAi pathway proteins in 13 nematode species for which genomic or transcriptomic datasets were available, with all outputs subjected to domain-structure verification. Our dataset spanned transcriptomes of Ancylostoma caninum and Oesophagostomum dentatum, and genomes of Trichinella spiralis, Ascaris suum, Brugia malayi, Haemonchus contortus, Meloidogyne hapla, Meloidogyne incognita and Pristionchus pacificus, as well as the Caenorhabditis species C. brenneri, C. briggsae, C. japonica and C. remanei, and revealed that: (i) Most of the C. elegans proteins responsible for uptake and spread of exogenously applied double stranded (ds)RNA are absent from parasitic species, including RNAi-competent plant-nematodes; (ii) The Argonautes (AGOs) responsible for gene expression regulation in C. elegans are broadly conserved, unlike those recruited during the induction of RNAi by exogenous dsRNA; (iii) Secondary Argonautes (SAGOs) are poorly conserved, and the nuclear AGO NRDE-3 was not identified in any parasite; (iv) All five Caenorhabditis spp. possess an expanded RNAi effector repertoire relative to the parasitic nematodes, consistent with the propensity for gene loss in nematode parasites; (v) In spite of the quantitative differences in RNAi effector complements across nematode species, all displayed qualitatively similar coverage of functional protein groups. In summary, we could not identify RNAi effector deficiencies that associate with reduced susceptibility in parasitic nematodes. Indeed, similarities in the RNAi effector complements of RNAi refractory and competent nematode parasites support the broad applicability of this research genetic tool in nematodes.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21666793 PMCID: PMC3110158 DOI: 10.1371/journal.pntd.0001176
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Core components of the Caenorhabditis elegans RNA interference (RNAi) pathway.
(1) Exogenously applied double-stranded RNA (dsRNA) and small interfering RNA (exo-siRNA) are thought to enter cells via SID (Systemic RNA Interference Defective) proteins SID-1/RSD-8 and SID-2. (2) Endogenous RNAi-based pathways begin in the nucleus; micro-interfering RNA (miRNA) synthesis begins with transcription of hairpin-looped primary miRNA (pri-miRNA) transcripts from intergenic, intronic or antisense regions. pri-miRNAs are processed by the DRSH-1/PASH-1 complex to pre-miRNA, which are exported from the nucleus by exportin proteins XPO-1, -2 and -3. Endogenous siRNAs (endo-siRNAs) are also produced from genomic regions, and exported by XPO-1, 2, and -3. (3) Both pre-miRNAs and exogenously applied dsRNA molecules are bound and cleaved by the dicer complex, which consists of the RNAse III-like nuclease DCR-1, the dsRNA-binding proteins RDE-1 and -4, the helicases DRH-1 and DRH-3/EKL-3, the RNA-dependent RNA-polymerase (RdRP) RRF-1, and the uncharacterized protein, AIN-1. Dicer cleaves dsRNA to produce siRNA molecules, and pre-miRNA to mature miRNA, both of which are substrates for the RNA-induced silencing complex (RISC). (4) Both siRNAs and miRNAs are the focus of a battery of inhibitors, which allow down-regulation of the RNAi response. (5) The RISC complex incorporates a single strand of miRNA or siRNA (termed the guide strand), and binds a complementary mRNA strand, eliciting gene silencing by either mRNA destruction or translational repression (6). The central catalytic component of RISC is an argonaute (AGO) protein, allied with the nuclease TSN-1, the RNA-binding protein VIG-1, and AIN-1. (7) The RNAi response may be amplified by the action of the RdRPs RRF-1 and -2, SMG-5, RDE-2/MUT-8 and MUT-7, which produce a population of single-stranded RNAs bearing N-terminal tri-phosphates from a target mRNA template. (8) These secondary siRNAs interact with Secondary-siRNA-specific AGOs (SAGO-1 and -2), terminating in down-regulation of target transcript. Secondary siRNAs can also spread between cells through RSD-2, -3 and -6, resulting in intercellular spread of the RNAi effect (9), and can be imported into the nucleus by NRDE-3, which elicits transcriptional silencing of nascent RNA transcripts as part of nuclear RISC (nucRISC) (10). siRNAs may also control aspects of nuclear RNAi, including histone methylation, chromatin formation and chromosome segregation (11). Dashed lines indicate miRNA-based pathways, solid lines indicate siRNA-based pathways.
Small RNA biosynthetic proteins.
|
| ||||||||||
| Clade | Species |
|
|
|
|
|
|
|
|
|
| I/2 |
| X | X | X | X | X | X | |||
| III/8 |
| X | X | X | X | X | X | X | ||
| III/8 |
| X | X | X | X | X | X | X | X | X |
| IV/12 |
| X | X | X | X | X | X | |||
| IV/12 |
| X | X | X | X | X | X | X | ||
| V/9 |
| X | X | X | X | X | X | X | ||
| V/9 |
| X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | ||
| V/9 |
| X | X | X | X | X | X | |||
| V/9 |
| X | X | X | X | X | X | |||
Species represented solely by expressed sequence tag (EST) datasets are not included, refer to Table S1. ‘X’ indicates presence of ortholog. Note that drh-2 is not included due to its sole presence as a pseudogene in Caenorhabditis elegans. See Dataset S1 for corresponding protein sequences.
dsRNA uptake and spreading, and siRNA amplification effectors.
|
| ||||||||||||
| Amplification Proteins | Spreading Proteins | |||||||||||
| Clade | Species |
|
|
|
|
|
|
|
|
|
|
|
| I/2 |
| X | X | X | X | |||||||
| III/8 |
| X | X | X | X | X | X | |||||
| III/8 |
| X | X | X | X | X | ||||||
| IV/12 |
| X | X | X | X | |||||||
| IV/12 |
| X | X | X | X | |||||||
| V/9 |
| X | X | X | X | |||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | |
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X | X | |
| V/9 |
| X | X | X | X | X | X | X | X | X | X | |
| V/9 |
| X | X | X | X | X | X | |||||
| V/9 |
| X | X | X | X | X | ||||||
| V/9 |
| X | X | X | X | X | X | |||||
Species represented solely by expressed sequence tag (EST) datasets are not included, refer to Table S1. ‘X’ indicates presence of ortholog. Note that rrf-2 is not shown, as it may represent a pseudogene found only in Caenorhabditis elegans. See Dataset S2 for corresponding protein sequences.
Argonautes (AGOs) and RNA-induced Silencing Complex (RISC) components.
|
| |||||||||||||||||||||||||||||||
| Argonautes | RISC Proteins | ||||||||||||||||||||||||||||||
| Clade | Species |
| R06C7.1 | C04F12.1 | F58G1.1 |
|
| C16C10.3 |
|
|
|
| T22B3.2 | T22H9.3 |
|
|
| F55A12.1 | T23D8.7 | nrde-3 |
| T23B3.2 | Y49F6A.1 | ZK1248.7 |
| C06A1.4 | C14B1.7 |
|
|
|
|
| I/2 |
| X | X | X | X | X | |||||||||||||||||||||||||
| III/8 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||
| III/8 |
| X | X | X | X | X | X | X | X | ||||||||||||||||||||||
| IV/12 |
| X | X | X | X | X | X | X | |||||||||||||||||||||||
| IV/12 |
| X | X | X | X | X | X | X | X | X | |||||||||||||||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||
Pseudogene in C. elegans.
Species represented solely by expressed sequence tag (EST) datasets are not included, refer to Table S1. ‘X’ indicates presence of ortholog. Caenorhabditis elegans-specific argonautes are not shown (M03D4.7; ZK218.8). See Dataset S3 for corresponding protein sequences.
RNAi inhibitors.
|
| ||||||||||
| Clade | Species |
|
|
|
|
|
|
|
|
|
| I/2 |
| X | X | X | ||||||
| III/8 |
| X | X | X | X | X | ||||
| III/8 |
| X | X | X | X | |||||
| IV/12 |
| X | X | X | ||||||
| IV/12 |
| X | X | |||||||
| V/9 |
| X | X | X | X | X | X | X | X | |
| V/9 |
| X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | |
| V/9 |
| X | X | X | X | |||||
| V/9 |
| X | X | X | X | X | ||||
| V/9 |
| X | X | X | X | X | ||||
| V/9 |
| X | X | X | X | |||||
Species represented solely by expressed sequence tag (EST) datasets are not included, refer to Table S1. ‘X’ indicates presence of ortholog. See Dataset S4 for corresponding protein sequences.
Nuclear RNAi effectors.
|
| ||||||||||||||||
| Clade | Species |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| I/2 |
| X | X | X | X | |||||||||||
| III/8 |
| X | X | X | X | X | X | X | X | |||||||
| III/8 |
| X | X | X | X | X | X | X | X | X | X | |||||
| IV/12 |
| X | X | X | X | X | X | X | ||||||||
| IV/12 |
| X | X | X | X | X | X | |||||||||
| V/9 |
| X | X | X | X | X | X | X | ||||||||
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| V/9 |
| X | X | X | X | X | X | X | X | X | X | X | ||||
| V/9 |
| X | X | X | X | X | X | |||||||||
| V/9 |
| X | X | X | X | X | ||||||||||
Species represented solely by expressed sequence tag (EST) datasets are not included, refer to Table S1 for these data. ‘X’ indicates presence of ortholog. See Dataset S5 for corresponding protein sequences.
Nematode RNAi effector protein complements.
| Clade | Species | Number of RNAi effector proteins |
| V/9 |
| 77 |
| V/9 |
| 65 |
| V/9 |
| 65 |
| V/9 |
| 63 |
| V/9 |
| 60 |
| V/9 |
| 46 |
| III/8 |
| 44 |
| V/9 |
| 40 |
| V/9 |
| 38 |
| V/9 |
| 36 |
| III/8 |
| 35 |
| IV/12 |
| 28 |
| IV/12 |
| 27 |
| I/2 |
| 22 |
Total number of RNAi effector proteins identified for each species.